Comparative Study of Olopatadine Hydrochloride 0.1% and Emedastine difumarate 0.05% Comparing their Clinical Efficacy and Adverse Effects in Allergic Conjunctivitis. mfm [Internet]. 2024 May 2 [cited 2025 Nov. 17];26(5). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/2774